PURE Bioscience, Inc. Convertible Notes Payable, Noncurrent
PURE Bioscience, Inc. (PURE) had Convertible Notes Payable, Noncurrent of $3.74 million as of 2026-04-30, per its 10-Q filed 2026-06-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2026-06-15
- 2026-04-30: Convertible Notes Payable, Noncurrent $3.74M.
- 2025-07-31: Convertible Notes Payable, Noncurrent $5.24M.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2026-04-30 | $3.74M 10-Q · filed 2026-06-15 |
| 2025-07-31 | $5.24M 10-Q · filed 2026-06-15 |